These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 29507612
1. Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome. Meijnikman AS, De Block CEM, Verrijken A, Mertens I, Van Gaal LF. Diabetol Metab Syndr; 2018; 10():12. PubMed ID: 29507612 [Abstract] [Full Text] [Related]
2. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population. Jin S, Chen Q, Han X, Liu Y, Cai M, Yao Z, Lu H. Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562 [Abstract] [Full Text] [Related]
3. Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score. Meijnikman AS, De Block CE, Verrijken A, Mertens I, Corthouts B, Van Gaal LF. J Diabetes Complications; 2016 Aug; 30(6):1043-9. PubMed ID: 27217020 [Abstract] [Full Text] [Related]
5. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population. Bernabe-Ortiz A, Perel P, Miranda JJ, Smeeth L. Prim Care Diabetes; 2018 Dec; 12(6):517-525. PubMed ID: 30131300 [Abstract] [Full Text] [Related]
6. Assessment of 1-Hour Postload Plasma Glucose, the Metabolic Syndrome, and the Finish Diabetes Risk Score in the Prediction of Type 2 Diabetes. Lizarzaburu-Robles JC, Garro-Mendiola A, Lazo-Porras M, Sanz-Pastor AG, Vento F, Lorenzo O. Endocr Pract; 2024 Dec; 30(12):1134-1140. PubMed ID: 39332500 [Abstract] [Full Text] [Related]
8. Diagnostic accuracy of the Finnish Diabetes Risk Score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University. Abdallah M, Sharbaji S, Sharbaji M, Daher Z, Faour T, Mansour Z, Hneino M. Diabetol Metab Syndr; 2020 Dec; 12():84. PubMed ID: 33014142 [Abstract] [Full Text] [Related]
11. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study. Salinero-Fort MA, Burgos-Lunar C, Lahoz C, Mostaza JM, Abánades-Herranz JC, Laguna-Cuesta F, Estirado-de Cabo E, García-Iglesias F, González-Alegre T, Fernández-Puntero B, Montesano-Sánchez L, Vicent-López D, Cornejo-Del Río V, Fernández-García PJ, Sánchez-Arroyo V, Sabín-Rodríguez C, López-López S, Patrón-Barandio P, Gómez-Campelo P, SPREDIA-2 Group. PLoS One; 2016 Dec; 11(7):e0158489. PubMed ID: 27441722 [Abstract] [Full Text] [Related]
12. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care. Arnardóttir E, Sigurðardóttir ÁK, Graue M, Kolltveit BH, Skinner T. BMC Public Health; 2023 Jan 31; 23(1):211. PubMed ID: 36721135 [Abstract] [Full Text] [Related]
16. The "metabolic syndrome" is less useful than random plasma glucose to screen for glucose intolerance. El Bassuoni EA, Ziemer DC, Kolm P, Rhee MK, Vaccarino V, Tsui CW, Kaufman JM, Osinski GE, Koch DD, Narayan KM, Weintraub WS, Phillips LS. Prim Care Diabetes; 2008 Sep 31; 2(3):147-53. PubMed ID: 18779039 [Abstract] [Full Text] [Related]